Literature DB >> 1267548

Prognosis of patients permanently paced for sick sinus syndrome.

A J Wohl, N J Laborde, J M Atkins, C G Blomqvist, C B Mullins.   

Abstract

In 39 patients (mean age, 66 years) treated for sick sinus syndrome (SSS) with pacemaker insertion, the long-term prognosis was studied. Fifteen patients (42%) died during the follow-up period of 6 to 59 months (mean, 25 months). Three patients were unavailable for follow-up. Eleven of the 15 deaths (73%) were cardiac-related, yet none could be associated with either an arrhythmia or pacemaker failure. Symptoms recurred or persisted after pacemaker insertion in 14 patients (mean age, 71 years), nine of whom died (31 deaths per 100 patient follow-up years). Twenty-two patients (mean age, 63 years) were asymptomatic after pacer insertion, six of whom died (11 deaths per 100 patient follow-up years). These follow-up results demonstrate a poor long-term prognosis in patients with SSS and persistent symptoms following permanent pacing.

Entities:  

Mesh:

Year:  1976        PMID: 1267548

Source DB:  PubMed          Journal:  Arch Intern Med        ISSN: 0003-9926


  5 in total

1.  Patient survival and instrument performance after permanent cardiac pacing.

Authors:  L B McGuire; W M O'Brien; S P Nolan
Journal:  Trans Am Clin Climatol Assoc       Date:  1977

2.  Approach to syncope.

Authors:  W T Branch
Journal:  J Gen Intern Med       Date:  1986 Jan-Feb       Impact factor: 5.128

3.  Survival in sinoatrial disorder (sick-sinus syndrome).

Authors:  D B Shaw; R R Holman; J I Gowers
Journal:  Br Med J       Date:  1980-01-19

4.  Age, sex, and ischaemic heart disease as prognostic indicators in long-term cardiac pacing.

Authors:  W R Fitzgerald; I M Graham; T Cole; D W Evans
Journal:  Br Heart J       Date:  1979-07

5.  Localization of the sinoatrial and atrioventricular nodal region in neonatal and juvenile ovine hearts.

Authors:  Jordan K Johnson; Brian K Cottle; Abhijit Mondal; Robert Hitchcock; Aditya K Kaza; Frank B Sachse
Journal:  PLoS One       Date:  2020-05-07       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.